Milnacipran improves pain in fibromyalgia patients: Patient E-diary results over 15 weeks in two randomized, double-blind, placebo-controlled trials

被引：0
|
作者：
Mease, Philip [1 ]
Palmer, Robert H. [2 ]
Qu, Peng [2 ]
Gendreau, R. Michael [3 ]
Zablocki, Rong [3 ]
机构：
[1] Seattle Rheurnatol Associates & Swedish Med Ctr, Seattle, WA USA
[2] Forest Res Inst, Jersey City, NJ USA
[3] Cypress Biosci Inc, San Diego, CA USA
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S383 / S383
页数：1
相关论文
共 50 条
  • [41] Gabapentin in the treatment of fibromyalgia - A randomized, double-blind, placebo-controlled, multicenter trial
    Arnold, Lesley M.
    Goldenberg, Don L.
    Stanford, Sharon B.
    Lalonde, Justine K.
    Sandhu, H. S.
    Keck, Paul E., Jr.
    Welge, Jeffrey A.
    Bishop, Fred
    Stanford, Kevin E.
    Hess, Evelyn V.
    Hudson, James I.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (04): : 1336 - 1344
  • [42] A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia
    Bennett, RM
    Clark, SC
    Walczyk, J
    AMERICAN JOURNAL OF MEDICINE, 1998, 104 (03): : 227 - 231
  • [43] Sodium Oxybate Reduces Pain and Improves Function and PGIC in Fibromyalgia: Results from an International, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial
    Swick, Todd
    Spaeth, Michael
    Choy, Ernest
    Alvarez-Horine, Sarah
    Wang, Y. Grace
    Benson, Beverly
    Bennett, Robert
    NEUROLOGY, 2010, 74 (09) : A280 - A280
  • [44] Low-dose naltrexone for treatment of pain in patients with fibromyalgia: a randomized, double-blind, placebo-controlled, crossover study
    Bested, Kirsten
    Jensen, Lotte M.
    Andresen, Trine
    Tarp, Grete
    Skovbjerg, Louise
    Johansen, Torben S. D.
    Schmedes, Anne V.
    Storgaard, Ida K.
    Madsen, Jonna S.
    Werner, Mads U.
    Bendiksen, Anette
    PAIN REPORTS, 2023, 8 (04) : E1080
  • [45] A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
    Masato Murakami
    Kenichi Osada
    Hiromichi Mizuno
    Toshimitsu Ochiai
    Levent Alev
    Kusuki Nishioka
    Arthritis Research & Therapy, 17
  • [46] Severe bleeding in patients with severe chronic ITP: Results from two double-blind, placebo-controlled, randomized clinical trials
    Bussel, J.
    Newland, A.
    Provan, A.
    Aivado, M.
    Stone, N.
    Poulin, R.
    Mayer, B.
    Arning, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 282 - 282
  • [47] A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with Fibromyalgia
    Mease, Philip J.
    Russell, I. Jon
    Arnold, Lesley M.
    Florian, Hana
    Young, James P.
    Martin, Susan A.
    Sharma, Uma
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (03) : 502 - 514
  • [48] A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
    Murakami, Masato
    Osada, Kenichi
    Mizuno, Hiromichi
    Ochiai, Toshimitsu
    Alev, Levent
    Nishioka, Kusuki
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [49] Zonisamide improves Parkinsonism in patients with DLB: A double-blind randomized placebo-controlled study
    Murata, M.
    Odawara, T.
    Hasegawa, K.
    Tamai, Y.
    Nakamura, M.
    Shimazu, R.
    Kosaka, K.
    MOVEMENT DISORDERS, 2015, 30 : S427 - S427
  • [50] Results from two randomized, double-blind, placebo-controlled trials evaluating the safety of regadenoson in patients with reactive airways disease
    Thomas, G.
    Leaker, B.
    Lieu, H.
    Tammelin, B.
    Milikien, D.
    Meng, L.
    Mathur, V.
    EUROPEAN HEART JOURNAL, 2007, 28 : 721 - 721
12345